Is Enliven Therapeutics, Inc. (ELVN) a Buy, Sell, or Hold?
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$52.035 USD
$0.3 (0.59%)
- Volume
- 116.21K
- Average Volume
- 1.33M
- Market Capitalization
- $3.72B
- P/E Ratio
- -31.73
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $52.42
- Year Low
- $14.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $40.32
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-19.9% DOWNSIDE
$65.00 Price Target
UPSIDE/DOWNSIDE HIGH
-35.0% DOWNSIDE
$80.00 Price Target High
UPSIDE/DOWNSIDE LOW
-11.8% DOWNSIDE
$59.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Robert Burns | $65 | $50.8 | 2026-07-09 06:05 AM | 28.0% |
| Mizuho Securities | Salim Syed | $62 | $37.51 | 2026-06-02 06:41 AM | 65.3% |
| Robert W. Baird | Colleen Kusy | $52 | $23.09 | 2025-06-16 08:45 AM | 125.2% |
| Robert W. Baird | Colleen Kusy | $40 | $24.05 | 2024-11-15 07:17 AM | 66.3% |
| Mizuho Securities | Salim Syed | $39 | $23.8 | 2024-09-23 07:00 AM | 63.9% |